| Factor Information | |
|---|---|
| Data ID | 340 |
| Factor | mortality |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | neonate motality with CHD |
| p Value | 0.03 |
| Conclusion | The mortality rate among infants diagnosed after birth was significantly greater than for those diagnosed in the antenatal period. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 440 |
| CHD Type | non-isolated CHD |
| CHD Subtype | D-TGA, IVS/D-TGA, VSD/AAO, IVS/AAO, VSD |
| Reference | |
|---|---|
| PMID | 30292491 |
| Year | 2019 |
| Title | Antenatal Detection of Treatable Critical Congenital Heart Disease Is Associated with Lower Morbidity and Mortality |
| Sample | ||
|---|---|---|
| Population | infant | |
| Source | data | |
| Region | New Zealand, Auckland | |
| Method | a population-based study | |
| Race | New Zealander | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD infants diagnosed prenatally(Treatment) | CHD infants diagnosed after birth(Control) |
| Number | 1(total: 97) | 11(total:156) |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.01 | 0.07 |
